Financhill
Back

Gilat Satellite Networks Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
30

GILT
Gilat Satellite Networks

Last Price:
4.44
Seasonality Move:
-3.24%
Sell
44

RARE
Ultragenyx Pharmaceutical

Last Price:
41.40
Seasonality Move:
-0.9%
Sell
30
Gilat Satellite Networks (GILT) is a Sell

Is Gilat Satellite Networks a Buy, Sell or Hold?

  • The current Gilat Satellite Networks [GILT] share price is $4.35. The Score for GILT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • GILT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GILT Stock Price Chart

What is Gilat Satellite Networks's stock price today?

  • The Gilat Satellite Networks share price today is $4.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GILT is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $40.50
    The current trend is relatively stagnant and RARE is experiencing slight buying pressure.

GILT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 23.16 Sell
Chaikin Money Flow: -147164 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.78 - 5.5) Sell
Bollinger Bands (100): (5.1 - 6.04) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: 494801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.79 - 41.97) Buy
Bollinger Bands (100): (40.81 - 48.79) Sell

GILT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.66 Sell
20-day SMA: 5.09 Sell
50-day SMA: 5.25 Sell
200-day SMA: 5.9 Sell
8-day EMA: 4.67 Sell
20-day EMA: 4.95 Sell
50-day EMA: 5.23 Sell
200-day EMA: 5.71 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.2 Buy
20-day SMA: 40.42 Buy
50-day SMA: 41.53 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.89 Buy
20-day EMA: 40.39 Buy
50-day EMA: 41.79 Sell
200-day EMA: 43.35 Sell

Gilat Satellite Networks Earnings Growth & GILT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Gilat Satellite Networks Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):